This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Garau M, Shah K, Towse A, Wang Q, Drummond M, Mason A.Assessment and appraisal of oncology medicines: does NICE's approach include all relevant elements? What can be learnt from international HTA experiences? Internet Document: [4 pages], 9 Feb 2009. Available from: URL: http://www.ohe.org
Rights and permissions
About this article
Cite this article
Update of NICE cancer drug assessment methods needed. Pharmacoecon. Outcomes News 573, 3 (2009). https://doi.org/10.2165/00151234-200905730-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200905730-00005